These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Phosphate treatment for hypercalcaemia]. Alveryd A; Boström H; Edgren B; Widström A Nord Med; 1967 Oct; 78(43):1395-400. PubMed ID: 6058619 [No Abstract] [Full Text] [Related]
23. Inhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats. Schibler D; Russell RG; Fleisch H Clin Sci; 1968 Oct; 35(2):363-72. PubMed ID: 4305530 [No Abstract] [Full Text] [Related]
24. Tamoxifen-induced hypercalcemia in metastatic breast cancer. Nemoto T; Rosner DH; Patel DJ; Wettingfeld RF; Bambrah SS; Dao TL N Y State J Med; 1980 Dec; 80(13):1980-2. PubMed ID: 6937756 [No Abstract] [Full Text] [Related]
25. Pulmonary calcification in a patient with multiple myeloma. Fayemi AO; Wisniewski M Chest; 1973 Dec; 64(6):765-9. PubMed ID: 4760025 [No Abstract] [Full Text] [Related]
27. The use of inorganic phosphate in the treatment of hypercalcemia. Massry SG; Popovtzer MM Med Times; 1969 Aug; 97(8):226-32. PubMed ID: 5795612 [No Abstract] [Full Text] [Related]
28. Reductions in renal mass and the nephropathy induced by mercury. Zalups RK Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453 [TBL] [Abstract][Full Text] [Related]
29. [Metastatic calcification following intravenous phosphate therapy in hypercalcaemia]. Halver B Ugeskr Laeger; 1972 Aug; 134(32):1667-9. PubMed ID: 5052351 [No Abstract] [Full Text] [Related]
30. Hypercalcemia and renal insufficiency complicating antacid treatment. Haspel Y; Dinbar A; Wolfstein I; Tulcinsky DB Med Chir Dig; 1974; 3(3):173-7. PubMed ID: 4431262 [No Abstract] [Full Text] [Related]
31. Extensive calcifications induced by hyperphosphataemia caused by phosphate-based enema in a patient after kidney transplantation. Eckstein J; Savic S; Eugster T; Pargger H; Gürke L; Pechula M; Steiger J; Mayr M Nephrol Dial Transplant; 2006 Jul; 21(7):2013-6. PubMed ID: 16735381 [No Abstract] [Full Text] [Related]
33. Renal function and alterations in plasma electrolyte levels in normocalcaemic and hypercalaemic patients with malignant diseases, given an intravenous infusion of mithramycin. Fillastre JP; Maitrot J; Canonne MA; Gray H; Jeanne C; Bastit P; Bourgeois T Chemotherapy; 1974; 20(5):280-95. PubMed ID: 4278249 [No Abstract] [Full Text] [Related]
34. Inorganic phosphate therapy of hypercalcemia. Christie DM; Azer M J Iowa Med Soc; 1969 Dec; 59(12):1092-5. PubMed ID: 5356745 [No Abstract] [Full Text] [Related]
36. Treatment of hypercalcemia with inorganic phosphate. Kistler HJ Helv Med Acta; 1967 Aug; 33(6):447-59. PubMed ID: 6081692 [No Abstract] [Full Text] [Related]
37. Bisphosphonates--role in cancer therapies. Mehrotra B J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811 [No Abstract] [Full Text] [Related]
38. [Chemical study on inhibition of calcification]. Rubin L; Tuchweber B Rev Can Biol; 1968 Dec; 27(4):313-9. PubMed ID: 4309624 [No Abstract] [Full Text] [Related]
39. Sodium phosphate tablets and acute phosphate nephropathy. Mackey AC; Green L; Amand KS; Avigan M Am J Gastroenterol; 2009 Aug; 104(8):1903-6. PubMed ID: 19661931 [No Abstract] [Full Text] [Related]